Diaceutics Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Diaceutics's estimated annual revenue is currently $22.3M per year.
- Diaceutics received $5.0M in venture funding in April 2018.
- Diaceutics's estimated revenue per employee is $187,487
- Diaceutics's total funding is $5.3M.
- Diaceutics has 119 Employees.
- Diaceutics grew their employee count by 45% last year.
- Diaceutics currently has 10 job openings.
|Steven Vitale||Managing Director, Marketing|
|Scott DeVore||Director, Key Accounts & Global Alliances|
|Steven Price||Senior Director Pharmaceutical Consulting, Engagement Team|
|Kevin Entwistle||Senior Director, IVD Commercialization|
|Ruchit Parikh||Director, Pharmaceutical Consulting|
|Jamil Glenn||Associate Marketing Director|
|Wayne Caldwell||Marketing Director|
|Peter DePaulo||Director, Software Engineer - Special Projects: Data Applications and Products|
|Kevin Monaghan||Senior Director Finance|
What Is Diaceutics?
Diaceutics is the diagnostic development and commercialization service provider. We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network. Our ultimate goal is to drive better testing to enable better treatment decisions for patients.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Trio, An FCB He...||$8M||43||-2%||N/A|
|PRI Healthcare ...||$11.3M||60||-5%||N/A|
|TAIHO ONCOLOGY ...||$39M||208||9%||N/A|
|LEO Pharma Inc....||$46.6M||248||3%||N/A|
Irish data analytics company Diaceutics reported a 34 per cent jump in half-year revenues in its maiden set of results as a publicly listed ...
(Alliance News) - Pharmaceuticals-focused data analytics firm Diaceutics PLC said Monday its maiden interim loss deepened amid listing costs ...
On its latest session, Diaceutics Plc ($DXRX) opened at 94.5, reaching a high of 96.34 and a low of 92.0 before closing at a price of 92.5.
|2018-04-06||$5.0M||Undisclosed||WhiteRock Capital Partners||Article|
Diaceutics Executive Hires
Diaceutics Hiring Plans
|Date||Number of Employees||Location||Reference|